Shopping Cart
Remove All
Your shopping cart is currently empty
Vulinacimab
Copy Product Info
😃Good
Catalog No. T76954Cas No. 2250342-36-8
Alias HLX-06
Vulinacimab (REGN910, SAR153192) is a humanized monoclonal antibody targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR2). By binding with high affinity to VEGFR2, it blocks the interaction of various ligands, including VEGF-A, with the receptor, thereby inhibiting downstream pro-angiogenic and pro-survival signaling pathways. It is a key tool for studying tumor angiogenesis and VEGFR2-related pathologies.
Vulinacimab
Vulinacimab
Copy Product Info😃Good
Catalog No. T76954Alias HLX-06Cas No. 2250342-36-8
Vulinacimab (REGN910, SAR153192) is a humanized monoclonal antibody targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR2). By binding with high affinity to VEGFR2, it blocks the interaction of various ligands, including VEGF-A, with the receptor, thereby inhibiting downstream pro-angiogenic and pro-survival signaling pathways. It is a key tool for studying tumor angiogenesis and VEGFR2-related pathologies.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry |
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Vulinacimab (REGN910, SAR153192) is a humanized monoclonal antibody targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR2). By binding with high affinity to VEGFR2, it blocks the interaction of various ligands, including VEGF-A, with the receptor, thereby inhibiting downstream pro-angiogenic and pro-survival signaling pathways. It is a key tool for studying tumor angiogenesis and VEGFR2-related pathologies. |
| Synonyms | HLX-06 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | VEGFR-2 |
| Cas No. | 2250342-36-8 |
| Isotype | IgG1 |
| Storage | store at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Vulinacimab | purchase Vulinacimab | Vulinacimab cost | order Vulinacimab
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.